What is Innovate's life sciences — other operating income?

Innovate (VATE) reported life sciences — other operating income of $0 in Q1 2026.

What does life sciences — other operating income mean?

This metric captures miscellaneous operating income or expenses that are not directly related to the core revenue-generating activities of the Life Sciences segment. It helps investors isolate non-recurring or peripheral operational items from the segment's primary business performance.

Innovate VATE Life Sciences — Other Operating Income

Other segment segments

Spectrum

$100K—

Infrastructure

$0-100%

Other financials

Income statement

See full

Revenue$364.8M+33.0%

Gross profit$53.5M+17.6%

Operating income$10.0M+194%

Net income-$16.8M+31.4%

EPS (diluted)-$1.29+31.7%

Balance sheet

See full

Cash & equivalents$134.6M+297%

Total debt$1.4B+11.6%

Total equity-$256.3M-25.5%

Total assets$936.8M+7.9%

Cash flow

See full

Operating cash flow$45.5M+423%

CapEx$200.0K-95.7%

Free cash flow$45.3M+341%

Valuation

See full

Market cap$254.69M+274%

Where this comes from

Reported directly by Innovate in its filing.

Tagged under the XBRL concept us-gaap:OtherOperatingIncomeExpenseNet.

The official record: Innovate’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Innovate's life sciences — other operating income.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Innovate's life sciences — other operating income?: Innovate (VATE) reported life sciences — other operating income of $0 in Q1 2026.
What does life sciences — other operating income mean?: This metric captures miscellaneous operating income or expenses that are not directly related to the core revenue-generating activities of the Life Sciences segment. It helps investors isolate non-recurring or peripheral operational items from the segment's primary business performance.